Document Detail


Dissolution of pancreatic stones by oral trimethadione in patients with chronic calcific pancreatitis.
MedLine Citation:
PMID:  7827299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of oral dissolution therapy for pancreatic stones was evaluated in patients with chronic calcific pancreatitis. The anti-epileptic agent trimethadione was given orally to 30 outpatients at a dose of 0.9-1.5 g daily. On plain X-ray films and CT scans of the abdomen, pancreatic stones began to be dissolved around 8 months of treatment, and diminished in size and number or disappeared in 21 patients (70%) during the mean follow-up period of 32 months. The effect of trimethadione treatment on dissolution of stones was not closely related to the aetiology of the disease, distribution and size of stones, previous history of surgical interventions, or the degree of pancreatic dysfunctions. In three patients who stopped this medication of their own accord, pancreatic stones re-increased or reappeared about 6 months later. During trimethadione treatment, impaired exocrine pancreatic function returned to normal in four of nine patients examined, and diabetes mellitus was well controlled by either diet therapy alone or oral hypoglycaemic agents in eight of 10 patients who did not need insulin before trimethadione treatment. Complete relief of pain was noted in 73% of patients during the treatment. Overall gains and no change in bodyweight were observed in 83% of patients. Mild photophobia was the most common side effect, but could be easily overcome by wearing sunglasses. No severe side effects were observed in the liver, kidney, blood or the eyeground. Pancreatic stones in 30 patients not treated with trimethadione neither disappeared nor diminished spontaneously. Trimethadione treatment may be a useful tool for chemical dissolution of pancreatic stones.
Authors:
A Noda; M Okuyama; H Murayama; K Takeuchi; T Yokota; T Kobayashi; T Takayama
Related Documents :
21461709 - Effect of the macroplastique implantation system for stress urinary incontinence in wom...
20426279 - Effect of antioxidant therapy on hospital stay and complications in patients with early...
23680969 - The randomized shortened dental arch study: oral health-related quality of life.
23494149 - Anal fistula plug vs mucosa advancement flap in complex fistula-in-ano: a meta-analysis.
24121829 - Arthroscopic partial anterior synovectomy of the knee on patients with haemophilia.
23796769 - Dermatology life quality index and side effects after topical photodynamic therapy of a...
20585969 - A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in fem...
22892139 - Combined proximal stent grafting plus distal bare metal stenting for management of aort...
21993599 - N-terminal pro-b-type natriuretic peptide level at long-term follow-up after atrial fib...
Publication Detail:
Type:  Case Reports; Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  9     ISSN:  0815-9319     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:    1994 Sep-Oct
Date Detail:
Created Date:  1995-02-23     Completed Date:  1995-02-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  478-85     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Aichi Medical University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Aged
Body Weight / drug effects
Calculi / complications,  drug therapy*,  physiopathology,  radiography
Chronic Disease
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pain / prevention & control
Pancreas / physiopathology
Pancreatitis / complications,  drug therapy*,  physiopathology,  radiography
Treatment Outcome
Trimethadione / administration & dosage*,  adverse effects
Chemical
Reg. No./Substance:
127-48-0/Trimethadione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in pa...
Next Document:  Effect of dimethadione administered intravenously on pancreatic secretion in dogs.